NTT DATA Selects Gestoos as Open Innovation Contest Champion
NTT DATA, a global IT services provider, announced today that it has selected Barcelona-based startup Gestoos as the Champion of the Open Innovation Contest 7.0 based on its AI solution that enables content and services to be operated simply with hand gestures. The winning proposal was chosen during the contest’s Grand Finale at NTT DATA headquarters in Toyosu, Tokyo on March 22. NTT DATA will collaborate with Gestoos to develop a concrete business plan based on the winning proposal.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180326005313/en/
NTT DATA's Kotaro Zamma and Gestoos founder German Leon (Photo: Business Wire)
The global competition, which is organized annually by NTT DATA, invites high-tech companies worldwide to submit proposals for IT services that offer potential to create new value in global society. The judging panel includes both NTT DATA personnel and outside experts.
The Gestoos AI solution recognizes and interprets subtle physical movements to enable people to operate content and services with just hand gestures. Gestoos’ patented proprietary algorithm uses live data to learn about interactions involving people, objects, spaces and vehicles. The entry was selected as the best idea for a previously unimagined IT service with high value-creation potential for public bodies, private companies and individuals, all customers of NTT DATA.
NTT DATA received 269 applications from around the world starting last December. Between December 6, 2017 and March 2, 2018, regional contests were held across four continents in 15 cities of 14 countries, up from 10 cities of 9 countries last year.
Each of the 15 regional contests selected a winner to present a proposal during the Grand Finale in Tokyo. The proposals covered fields such as fintech, medtech, insurtech, security, artificial intelligence (AI), augmented reality, authentication, AI-supported optical character recognition and navigation.
In addition to the winning prize, an Audience Award was presented to ftcash (Mumbai) and Judges Awards were presented to FOMO Pay (Singapore) and SightCall (San Francisco) by NTT DATA representatives on the judging panel.
German Leon, founder of Gestoos, said: “We are very excited to win this contest because collaboration with NTT DATA will be a huge step for our business. Our AI solution not only sees hands and objects, it sees people in action and understands space and context. It uses live data to learn how to make interactions more human. Ultimately, Gestoos redefines interactions for machines, people and spaces. In collaboration with NTT DATA, we hope to create new and exciting experiences for consumers and industries.”
Kotaro Zamma, Head of NTT DATA’s Open Innovation and Business Incubation, said: “This year’s contest received very strong local support from NTT DATA’s group companies and partners overseas. By promoting open innovation, the hope is that our contest will continue to stimulate new business creation around the world. Going forward, we would like to be a catalyst for open innovation that leads to meaningful changes in global society.”
NTT DATA’s open innovation initiatives have led to the creation of numerous new businesses already. Together with Social Coin, last year’s winner, NTT DATA recently established the “Regional Issue Discovery Lab” to apply AI technology toward innovative solutions that address regional issues.
Each regional contest this year was organized in collaboration with NTT DATA group companies and regional partners: NTT DATA UK and Innovate Finance (UK), everis (Spain, Brazil, Portugal and Chile), MaRS Discovery District (Canada), Institute of Software, Chinese Academy of Sciences (China), NTT DATA Inc. and Runway (U.S.), Deloitte Israel (Israel), Startupbootcamp and Rainmaking Innovation (Singapore, Australia and India) and Asian Payment Network (Singapore).
NTT DATA will hold the Open Innovation Contest in worldwide venues again next year. NTT DATA is confident that the contests are winning propositions for the participating startup companies as well as NTT DATA, client companies of NTT DATA, and global society.
For more about the contestants: http://oi.nttdata.com/en/contest/result.
About NTT DATA
NTT DATA is a leading IT services provider and global innovation partner headquartered in Tokyo, with business operations in over 50 countries. Its emphasis is on long-term commitments, combining global reach with local intimacy to provide premier professional services varying from consulting and systems development to outsourcing. For more information, visit www.nttdata.com
All products, corporations and organization names are registered trademarks or corporate trademarks.
List of Contestants
The following contestants presented at the Grand finale. An asterisk (*) indicates inaugural participation in the contest.
Institute of Software CAS
Weber Shandwick (for NTT DATA Corporation)
(Ms.) Ayumi Matsubara, +81-90-9006-5841
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Brightree Acquires Mobile Delivery Provider Apacheta to Streamline HME Delivery17.12.2018 14:05 | Pressemelding
Brightree, a leading provider of cloud-based software helping out-of-hospital providers improve business performance and patient outcomes, today announced it has acquired privately held mobile delivery and cloud-based software-as-a-service (SaaS) provider Apacheta Corporation, further expanding the SaaS portfolio of Brightree’s owner, ResMed. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181217005121/en/ The terms of the transaction were not disclosed. Apacheta offers mobile applications that empower companies to automate and streamline business processes in route sales, field marketing, pick-up and delivery, transportation and field services. Apacheta and its Media, PA-based employees will join Brightree, whose platform it has been integrated with since 2015. A secure mobile delivery module for ordering and tracking medical equipment was the number one feature request of HMEs in a recent customer satisfaction survey. Brigh
Transphorm’s High Voltage GaN FETs Amp Up Marotta Controls’ Military Grade High Frequency Power Supply17.12.2018 14:00 | Pressemelding
Transphorm Inc.—the leader in the design and manufacturing of the highest reliability and first JEDEC- and AEC-Q101 qualified gallium nitride (GaN) semiconductors—today announced with Marotta Controls that the Aerospace and Defense supplier’s upcoming power supply unit (PSU) replaces incumbent Silicon (Si) MOSFETs with high voltage GaN PQFN devices to offer advanced benefits. Marotta’s latest design operates at high frequency in a conduction-cooled mechanically constrained envelope. The supply’s topology features hard switching and an automatic transformer RESET capability where transistor voltage stresses are clamped to the input voltage. The GaN devices increase the PSU’s efficiency dramatically and alleviate a complex thermal design in the small form factor package. “The demand on our power supplies and expectation of performance is high,” explained Mike Scruggs, Principal Engineer, Marotta Controls. “This particular complex PSU needed to reliably convert and distribute power in a s
New Phase 3 data demonstrate superiority of TREMFYA®▼ (guselkumab) vs Cosentyx® (secukinumab) in delivering PASI 90 responses in the treatment of moderate to severe plaque psoriasis at week 4817.12.2018 12:56 | Pressemelding
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from the ECLIPSE study demonstrating that TREMFYA® (guselkumab) was superior to Cosentyx® (secukinumab)* in treating adults with moderate to severe plaque psoriasis for the primary endpoint assessed at week 48. Data from the multicentre, randomised, double-blind head-to-head Phase 3 study demonstrated that 84.5 percent of patients treated with guselkumab achieved at least 90 percent improvement in their baseline Psoriasis Area Severity Index (PASI) score at week 48, compared with 70.0 percent of patients treated with secukinumab (p<0.001).1 These data, presented at the 3rd Inflammatory Skin Disease Summit (ISDS) in Vienna, 12–15 December, mark the first-ever results from a head-to-head study comparing an interleukin (IL)-23-targeted biologic therapy (guselkumab) with an IL-17 inhibitor (secukinumab). ECLIPSE is Janssen’s fourth Phase 3 study for guselkumab in plaque psoriasis2-4 and is part of a comprehen
Celgene Corporation Announces Celgene Cancer Care Links™ Program Grant Recipients17.12.2018 12:30 | Pressemelding
Celgene Corporation (NASDAQ:CELG) today announced ten programs selected for funding under its Celgene Cancer Care Links™ program, an initiative designed to support cancer healthcare capacity building in resource-constrained countries around the world. The programs selected are expected to support established institutions partnering with in-country medical centers that provide essential cancer care services including awareness and education, prevention, diagnosis and care. The Celgene Cancer Care Links program is an initiative of Celgene Global Health, which focuses on healthcare challenges facing patients in developing parts of the world. “Celgene Cancer Care Links is another program we have created to make a meaningful impact for patients and healthcare systems around the world,” said Mark J. Alles, Chairman and Chief Executive Officer of Celgene. “We are excited to announce the first round of grants through this initiative and wish these world-renowned organizations and institutions
Ras Al Khaimah Marks New Year’s Eve with Amazing Fireworks and New Guinness World Record Bid17.12.2018 11:14 | Pressemelding
This New Year’s Eve, Ras Al Khaimah is the place to be as the Emirate readies to host the most spectacular celebration with a 12-minute fireworks display - the bid for a new Guinness World Record display - and an array of family-oriented activities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181217005309/en/ Marjan, Ras Al Khaimah’s master-developer of freehold projects, will manage the show to mark 2019 with a glittering array of activities that will entertain all at its flagship development, Al Marjan Island. With three additional viewing areas around Al Marjan Island, New Year’s Eve in Ras Al Khaimah has fun and thrills in store for local and international visitors. Abdulla Al Abdouli, Managing Director & CEO of Marjan, said: “This year, we are offering exciting family activities that will delight all in the run-up to the amazing fireworks display that aims to set a new Guinness World Record. The event will position t
Mobidiag Announces Joint Venture with Autobio Diagnostics and €10m Equity Investment17.12.2018 09:52 | Pressemelding
Mobidiag Ltd., a commercial stage molecular diagnostics company addressing the spread of antimicrobial resistance, today announces that it has entered into a joint venture (‘JV’) agreement with Autobio Diagnostics (‘Autobio’), one of the leading clinical diagnostics companies in China, to commercialise the Novodiag® platform in China. In addition, Mobidiag announces that it has secured a separate €10m equity investment from Autobio. Lynx Financial (HK) Ltd, served as the exclusive financial advisor to Mobidiag in this transaction. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181217005272/en/ Mobidiag and Autobio will jointly invest €12.3m to establish a joint venture company in China. Autobio will invest €8m in cash to hold 65%, and Mobidiag will invest €4.3m to hold 35%. Mobidiag will grant to the JV an exclusive license for human infectious disease assays (except for sepsis) for China. Initial activities of the JV will i